Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.
Source: insidermonkey.com
Stay updated with breaking news from David Lebowitz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75.
Schrödinger, Inc. reports earnings inline with expectations. Reported EPS is $-0.76 EPS, expectations were $-0.76.
EXEL earnings call for the period ending March 31, 2024.
Letters to the editor
A disabled woman was sent to the ER hundreds of times by staff at a Laurelton group home -- who were caught on video physically abusing her.